Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Bioassays and biological stability.

¹Genetics Institute Inc., Andover, MA, USA.

Developments in Biological Standardization

|August 27, 1999

Summary

This summary is machine-generated.

Bioassays remain valuable for monitoring biotechnology product stability, offering unique insights into conformational changes. Despite advancements in characterization techniques, bioassays provide sensitive and accessible data for routine quality control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation.

Mucosal immunology·2013

Same author

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency.

Gene therapy·2009

Same author

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Neurology·2009

Same author

Scaling-up production of recombinant AAV vectors for clinical applications.

Current opinion in drug discovery & development·2009

Same author

Manufacturing and characterizing AAV-based vectors for use in clinical studies.

Gene therapy·2008

Same author

ISBT Code 128 implementation at a regional blood center.

Transfusion·2005

Same journal

International challenges and public policy issues.

Developments in biological standardization·2000

Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000

Same journal

The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics.

Developments in biological standardization·2000

Same journal

Cytokine and growth factor standardization: the need for research to answer modern issues.

Developments in biological standardization·2000

Same journal

Alternatives to the use of animals for bacterial toxins and antitoxins.

Developments in biological standardization·2000

Same journal

Cell substrates: lessons learned and challenges remaining.

Developments in biological standardization·2000

See all related articles

Area of Science:

Biotechnology
Analytical Chemistry
Biochemistry

Background:

Modern biochemical and biophysical techniques have advanced the characterization of biotechnology products.
This progress has led to questions regarding the continued relevance of traditional bioassays.

Purpose of the Study:

To evaluate the ongoing utility of bioassays in the context of well-characterized biotechnology products.
To highlight the unique advantages bioassays offer in specific applications, such as stability monitoring.

Main Methods:

Comparison of bioassay sensitivity and information content against modern biochemical and biophysical techniques.
Assessment of bioassays in routine stability monitoring scenarios.

Main Results:

Related Experiment Videos

Bioassays provide unique data not obtainable through other methods, especially for conformational changes.
Bioassays are relatively easy to perform and demonstrate superior sensitivity compared to most structural techniques.
They are effective in detecting previously unidentified alterations in product quality.

Conclusions:

Bioassays retain significant value, particularly for routine stability monitoring of biotechnology products.
Their sensitivity, ease of use, and ability to detect subtle changes ensure their continued importance in quality control.